Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Plus Therapeutics Inc 4200 MARATHON BLVD SUITE 200 AUSTIN TX 78756 USA

www.plustherapeutics.com P: 737-255-7194 F: 210-974-6901

Description:

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.

Key Statistics

Overview:

Market Capitalization, $K 9,070
Enterprise Value, $K 4,500
Shares Outstanding, K 5,704
Annual Sales, $ 4,910 K
Annual Net Income, $ -13,320 K
Last Quarter Sales, $ 1,280 K
Last Quarter Net Income, $ -2,940 K
EBIT, $ -14,110 K
EBITDA, $ -13,290 K
60-Month Beta 0.65
% of Insider Shareholders 2.32%
% of Institutional Shareholders 3.28%
Float, K 5,572
% Float 97.68%
Short Volume Ratio 0.36

Growth:

1-Year Return 22.73%
3-Year Return -94.52%
5-Year Return -96.91%
5-Year Revenue Growth 33.79%
5-Year Earnings Growth 99.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 08/14/24
Next Earnings Date 10/29/24
Earnings Per Share ttm -3.16
EPS Growth vs. Prev Qtr 5.33%
EPS Growth vs. Prev Year -20.34%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/01/23

PSTV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -127.52%
Profit Margin % -271.28%
Debt/Equity -0.43
Price/Sales 1.81
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.34
Interest Coverage -32.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar